Enex has pursued multiple defensive measures to maintain its listing. In March 2026 the board approved a 5-for-1 reverse stock split, completing the re-listing on May 20, followed by the retirement of 141,274 treasury shares (1.18% of shares outstanding) in June.
Management also purchased shares on the open market to signal commitment.
On July 30, 2026, Chairman Park Jin-gyu and seven others signed a control-transfer agreement to sell their 28.48% stake (KRW 3,400 per share, KRW 11.48 billion total) to Enex Future Growth Association, at a price roughly 128% above the closing price on the contract date.
However, reports that the final payment date was pushed back from September 4 to December 30 and that the entity funding the related rights issue changed leave uncertainty around the deal's completion.
Separately, a KRW 5 billion third-party share allotment (2 million new shares at KRW 2,500 each) is underway to fund operations, with the new-share listing still pending.
On the business side, under the 'Enex 3.0' strategy of reducing reliance on B2B builder supply and pivoting toward a lifestyle-solutions platform, the company has invested in Dermatobio, partnered with China's Yimei Biotech, and is building a digital platform, though these initiatives have not yet shown up in financial results.
Key items to watch going forward are whether the administrative-issue risk is resolved, whether the control transaction actually closes, and whether the new capital raise translates into improved cash flow.